Follow
Andrii Domanskyi
Andrii Domanskyi
Principal investigator, University of Helsinki
Verified email at helsinki.fi - Homepage
Title
Cited by
Cited by
Year
Effects of neurotrophic factors in glial cells in the central nervous system: expression and properties in neurodegeneration and injury
S Pöyhönen, S Er, A Domanskyi, M Airavaara
Frontiers in physiology 10, 422442, 2019
2002019
Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling
C Rieker, D Engblom, G Kreiner, A Domanskyi, A Schober, S Stotz, ...
Journal of Neuroscience 31 (2), 453-460, 2011
1822011
Interplay between MicroRNAs and oxidative stress in neurodegenerative diseases
J Konovalova, D Gerasymchuk, I Parkkinen, P Chmielarz, A Domanskyi
International journal of molecular sciences 20 (23), 6055, 2019
1602019
Solitary HERV-K LTRs possess bi-directional promoter activity and contain a negative regulatory element in the U5 region
AN Domansky, EP Kopantzev, EV Snezhkov, YB Lebedev, C Leib-Mosch, ...
FEBS letters 472 (2-3), 191-195, 2000
1422000
Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models
A Domanskyi, C Geiβler, IA Vinnikov, H Alter, A Schober, MA Vogt, P Gass, ...
The FASEB Journal 25 (9), 2898-2910, 2011
1332011
Dicer and microRNAs protect adult dopamine neurons
P Chmielarz, J Konovalova, SS Najam, H Alter, TP Piepponen, H Erfle, ...
Cell death & disease 8 (5), e2813-e2813, 2017
972017
MANF promotes differentiation and migration of neural progenitor cells with potential neural regenerative effects in stroke
KY Tseng, JE Anttila, K Khodosevich, RK Tuominen, M Lindahl, ...
Molecular therapy 26 (1), 238-255, 2018
842018
Prospects of neurotrophic factors for Parkinson's disease: comparison of protein and gene therapy
A Domanskyi, M Saarma, M Airavaara
Human gene therapy 26 (8), 550-559, 2015
842015
Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance
A Domanskyi, H Alter, MA Vogt, P Gass, IA Vinnikov
Frontiers in cellular neuroscience 8, 275, 2014
832014
Neuron-specific genome modification in the adult rat brain using CRISPR-Cas9 transgenic rats
S Bäck, J Necarsulmer, LR Whitaker, LM Coke, P Koivula, EJ Heathward, ...
Neuron 102 (1), 105-119. e8, 2019
772019
Update of neurotrophic factors in neurobiology of addiction and future directions
M Koskela, S Bäck, V Võikar, CT Richie, A Domanskyi, BK Harvey, ...
Neurobiology of disease 97, 189-200, 2017
732017
AAV vector-mediated gene delivery to substantia nigra dopamine neurons: implications for gene therapy and disease models
K Albert, MH Voutilainen, A Domanskyi, M Airavaara
Genes 8 (2), 63, 2017
712017
Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription
N Rouleau, A Domans' kyi, M Reeben, AM Moilanen, K Havas, Z Kang, ...
Molecular biology of the cell 13 (6), 2106-2119, 2002
572002
MANF is essential for neurite extension and neuronal migration in the developing cortex
KY Tseng, T Danilova, A Domanskyi, M Saarma, M Lindahl, M Airavaara
eneuro 4 (5), 2017
522017
Back and to the future: from neurotoxin‐induced to human Parkinson's disease models
M Airavaara, I Parkkinen, J Konovalova, K Albert, P Chmielarz, ...
Current Protocols in Neuroscience 91 (1), e88, 2020
492020
Pancreatic β-cell protection from inflammatory stress by the endoplasmic reticulum proteins thrombospondin 1 and mesencephalic astrocyte-derived neutrotrophic factor (MANF)
DA Cunha, M Cito, FA Grieco, C Cosentino, T Danilova, L Ladrière, ...
Journal of Biological Chemistry 292 (36), 14977-14988, 2017
482017
GDNF/RET signaling pathway activation eliminates Lewy body pathology in midbrain dopamine neurons
P Chmielarz, Ş Er, J Konovalova, L Bandres, I Hlushchuk, K Albert, ...
Movement Disorders 35 (12), 2279-2289, 2020
432020
Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson’s disease
K Albert, MH Voutilainen, A Domanskyi, TP Piepponen, S Ahola, ...
Journal of neuroscience research 97 (3), 346-361, 2019
432019
Pre-α-pro-GDNF and pre-β-pro-GDNF isoforms are neuroprotective in the 6-hydroxydopamine rat model of Parkinson's disease
AM Penttinen, I Parkkinen, MH Voutilainen, M Koskela, S Bäck, A Their, ...
Frontiers in neurology 9, 371449, 2018
322018
Neuron-astrocyte transmitophagy is altered in Alzheimer's disease
R Lampinen, I Belaya, L Saveleva, JR Liddell, D Rait, MT Huuskonen, ...
Neurobiology of Disease 170, 105753, 2022
312022
The system can't perform the operation now. Try again later.
Articles 1–20